After contracting and beating a coronavirus infection, a body needs time to rest, to recover its health and strength. Sadly, for some children, that isn't what happens next.A mysterious, new disease called multisystem inflammatory syndrome in children (MIS-C, and also known as paediatric multisystem inflammatory syndrome or PIMS) has affected hundreds of children around the…
Sisa Ntshona, CEO of SA Tourism (Supplied) South Africa is the most popular destination for travellers in a post-Covid-19 world, according to Tourlane, an online travel website.The survey solicited views of international tourists via Tourlane's newsletter and social networks and counted the number of responses in the company's four main languages: German, French, Dutch and…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f